We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Itaconix Plc | LSE:ITX | London | Ordinary Share | GB00BPK3YZ68 | ORD 50P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 36.00 | 23.76% | 187.50 | 38,408 | 15:44:20 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 185.00 | 190.00 | 191.50 | 155.00 | 155.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | USD 7.87M | USD -1.54M | USD -0.1139 | -16.46 | 20.43M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:20:24 | O | 256 | 190.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/7/2024 | 18:35 | ALNC |  TRADING UPDATES: Journeo wins deals; Strip Tinning earnings warning |
| 16/7/2024 | 07:00 | UK RNS | Itaconix PLC H1 2024 Trading Update |
| 20/5/2024 | 15:03 | UK RNS | Itaconix PLC Result of AGM |
| 20/5/2024 | 10:34 | ALNC | Itaconix shares rise on new orders and regulatory approvals |
| 20/5/2024 | 07:00 | UK RNS | Itaconix PLC AGM Statement and Trading Update |
| 29/4/2024 | 13:59 | ALNC | Itaconix launches two new plant-based ingredients for detergents |
| 29/4/2024 | 07:00 | UK RNS | Itaconix PLC Launch of two plant-based performance ingredients |
| 19/4/2024 | 07:00 | UK RNS | Itaconix PLC Grants of Options & PDMR dealings |
| 15/4/2024 | 11:49 | ALNC | EARNINGS: Mobeus VCT has good 2023; Itaconix, Engage XR narrow losses |
| 15/4/2024 | 07:00 | UK RNS | Itaconix PLC Preliminary Results and Notice of AGM |
Itaconix (ITX) Share Charts1 Year Itaconix Chart |
|
1 Month Itaconix Chart |
Intraday Itaconix Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 14:03 | Itaconix formerly Revolymer | 10,181 |
| 06/12/2022 | 16:01 | where's lucky | 38 |
| 15/7/2022 | 13:33 | GET OUT BEFORE ITS TOO LATE!!!!(11/04/02) | 149 |
| 16/6/2021 | 14:54 | Inter_X holders ready to do a big brown plop soon | 152 |
| 16/6/2021 | 14:45 | Anyone still holding any of this ? | 28 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:20:26 | 190.00 | 256 | 486.40 | O |
| 2024-07-26 15:11:26 | 190.00 | 900 | 1,710.00 | O |
| 2024-07-26 14:47:44 | 186.10 | 542 | 1,008.66 | O |
| 2024-07-26 14:44:20 | 190.00 | 4 | 7.60 | O |
| 2024-07-26 14:44:20 | 185.00 | 7 | 12.95 | O |
| Top Posts |
|---|
Posted at 25/7/2024 11:34 by rivaldo Nice post on LinkedIn last week:"The plant-based chemicals revolution gathers speed. Itaconix Corporation is honored to be cited as one of 9 key players impacting the value chain. Thx for the Proactive interview elsol, very positive. There's a good summary of it elsewhere by SmartInvestment: "1. In yesterday’s interview John Shaw stated that Absolute gross profit in H1 2024 was similar to a year earlier due to the improved gross margin. That is despite offloading its low margin customer. 2. Gross profit margin increased to a whopping 38% in H1 2024 compared to 28% a year earlier. That is some progress. 3. Link I posted this morning to hair products shows massive potential application: VELASOFT® NE 100 TDS - Frizz reduction and curl retention VELAFRESH™ ZP - Plant-based solution for malodor neutralization Itaconix® SF 505 TDS- Natural conditioning, better foam texture & stability, and enhanced viscosity Any of these 3 applications could land a massive multi-million annual $ customer(s)and I anticipate such news in H2. 4. Yesterday’s update on superabsorbents was very welcome news and makes me 100% certain Itaconix read this share chat as a number of us were disappointed not to get an update in the recent trading update. Once the company finalises its product in H2 it can hit 2025 with a massive marketing campaign. Again one or more large customers in this yield could be multi-million annual dollar business. 5. The leather application came out of the blue earlier this year, and just goes to show how diversified this company is becoming. I must confess I still don’t realise the full potential of the leather sector but I imagine it’s big as John is very excited about this. 6. Diversification into Mineral products. Another application we have limited knowledge about but another area John has mentioned a few times this year. 7. All this is on top of its bread and butter dishwasher business which we learnt yesterday has diversified into a gel delivery option with the landing of a major southern European customer. 8. When you add all the above developments together there is a very credible path to becoming a $100m revenue company in the next 5 years. 9. The recent off book trades show institutional investor appetite for Itaconix and they want to get in at a cheap a price as possible. They must see the current share price as the bottom. Golden rule “follow the money”." |
Posted at 24/7/2024 13:01 by dexdringle Well, that interview boosted the share price nicely. Oh, wait. What ?Shaw and the board need to start buying significant numbers of shares at market price out of their own pockets. If, knowing what they know, they aren't buying then why would anyone else ? |
Posted at 02/7/2024 10:00 by purchaseatthetop The market looks at a less than 30% gross margin and says “WTF?”. The customers are not willing to pay a premium for the USP so that is why the share price is where it is. Gross margin should be 60%. The fundamental question is why not? |
Posted at 02/7/2024 09:54 by purchaseatthetop I thought that only ITX could use it in the right formulation concentration to actually work. Anybody can use itaconic acid but ITX has an IP moat. |
Posted at 14/6/2024 18:28 by dexdringle 13.5 million shares in issue and the sale of 11,000 shares (net) for the day moves the share price down by 7.5% ?So the sale of £16,000 of shares of a company with a £20 million market cap sends the market cap down by £1.5 million. Righty-ho. |
Posted at 17/5/2024 09:18 by parob Some people have sold out, they're bitter and would love to see the share price drop further whilst others are taking advantage of the low price. The IP and revenues here are worth much more than the current market cap of £18M imo. |
Posted at 08/4/2024 20:45 by elsol It's a big number Dex prob 80m GBP at least. Well above current Mcap. In process R&D in gestation about to hatch at last! ITX has taken a few years. Can't wait for diversification success news as will derisk ITX product set,bring back investor confidence and share price will rebound north of placing price. |
Posted at 02/4/2024 19:15 by elsol PTT,The new Fcst 24 is an optical financial worst case scenario (low case) assuming the worst outcome and total loss of revenues going forwards for this client (a client that appears to have v low profitability overall and hence low contribution to the value of the firm in totality irrespective to its total revenue - in all probability we will not see the worst case evolve into the actual revenue outturn since the party may order more than the worst case for the rest of FY 24 and may return in FY25. In any case much of the value of ITX is not currently generating revenue but has value nevertheless. Its subsumed in the share price so my take is yes we may have lost a chunk of revenue - its not really profitable so times by, say, 75% then consider R&D projects overlay value so you cannot say we lost x% revenue and that translates to x% share price fall as we are dealing with apples (profitable revenue) and oranges (non-profitable revenue and grapefruit (future much bigger very profitable revenues) that can occupy the plant capacity. See my note on LSE chat re: plant capacity and value maximisation of total ITX portfolio (existing and new customers) which may mean the decision today is actually value accretive as a portfolio rather than destroying value. Its a strange concept but one you have to get your head around with this stock if you are serious medium term invetor. |
Posted at 28/2/2024 08:22 by rivaldo Forget the past - look at the huge potential from where ITX are now.ITX are at this stage of their evolution more likely to be valued at a multiple of recurring revenues given that this is where their core attraction lies in terms of "stickability" etc. Such a multiple could conservatively be say 5 times revenues - so to achieve a £60m valuation ITX would only need £12m revenues. Not such a big step from where ITX are today. And even if ITX were to be valued on a P/E ratio at a £60m m/cap, if ITX were forecast to achieve fast growth in profitability having reached an optimum point in scaling up, they'd be more likely to be valued on a P/E of 20 or more, thus requiring "only" a £3m PAT at the maximum. |
Posted at 15/8/2023 08:00 by bamboo2 15 August 2023Itaconix plc ("Itaconix" or the "Company") Share Consolidation Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, announces details of its share consolidation ("Share Consolidation"). The Share Consolidation was approved by shareholders at the Company's Annual General Meeting on 28 June 2023. Rationale for the Share Consolidation The Directors consider that it is in the best interests of the Company's long-term development as a public quoted company to support share trading through the Company's US OTC listing, with a more manageable number of issued ordinary shares and corresponding share price. Details of the Share Consolidation Every existing 50 ordinary shares of GBP0.01 each in the capital of the Company (each an "Existing Ordinary Share") in issue and shown in the register of members of the Company at 6.00 p.m. (London time) on the Record Date (as defined below) will be consolidated into one ordinary share of GBP0.50 each (each a "New Ordinary Share"). The Company intends, immediately prior to the Share Consolidation being effected, to issue 45 additional Existing Ordinary Shares to enable the total number of Existing Ordinary Shares in issue being exactly divisible by 50. Since these additional shares will only represent a fraction of a New Ordinary Share, this fraction will be combined with other fractional entitlements and sold pursuant to the arrangements for fractional entitlements described below. As a result of this allotment the number of Existing Ordinary Shares in issue immediately prior to the Share Consolidation will be 674,306,100 Existing Ordinary Shares. In accordance with the Company's articles of association (the "Articles"), no shareholder will, pursuant to the Share Consolidation, be entitled to receive a fraction of a New Ordinary Share. The Directors will make arrangements to aggregate all the fractions of New Ordinary Shares into whole New Ordinary Shares and to sell the resulting New Ordinary Shares for the best price reasonably obtainable. Where the proceeds to which a shareholder would be entitled from the sale of the fractional entitlements would amount to less than GBP5.00, in accordance with the Articles, such amounts will not be distributed to the relevant shareholders and will be aggregated and retained for the benefit of the Company in accordance with the Articles. Rights attaching to New Ordinary Shares The New Ordinary Shares arising upon implementation of the Share Consolidation will have the same rights as the Existing Ordinary Shares including voting, dividend, return of capital and other rights. Effects on options The entitlements to ordinary shares of holders of securities or instruments convertible into ordinary shares (such as share options) are expected to be adjusted to reflect the Share Consolidation . Admission of the New Ordinary Shares Application will be made to the London Stock Exchange for the 13,486,122 New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and that dealings in the New Ordinary Shares will commence at 8.00 a.m. BST on 22 August 2023. Following Admission, the share capital of the Company will be comprised of 13,486,122 New Ordinary Shares. Shareholders who hold Existing Ordinary Shares in uncertificated form will have such shares disabled in their CREST accounts and their CREST accounts will be credited with the New Ordinary Shares following Admission to AIM, which is expected to be on 22 August 2023. Following the Share Consolidation, existing share certificates will cease to be valid and new share certificates will be dispatched to those shareholders who hold their Existing Ordinary Shares in certificated form. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
